These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 15741002

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL.
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [Abstract] [Full Text] [Related]

  • 3. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Fernø J, Gebhardt S, Hinney A, Remschmidt H, Krieg JC, Mehler-Wex C, Nöthen MM, Hebebrand J, Steen VM.
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [Abstract] [Full Text] [Related]

  • 4. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V, Doknic M, Maric N, Pekic S, Damjanovic A, Miljic D, Popovic S, Miljic N, Djurovic M, Jasovic-Gasic M, Dieguez C, Casanueva FF.
    Neuroendocrinology; 2007 Mar; 85(4):249-56. PubMed ID: 17570902
    [Abstract] [Full Text] [Related]

  • 5. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctôt G, Saindon J, Vincent A, Gagnon S, Tremblay A.
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [Abstract] [Full Text] [Related]

  • 6. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
    Hrdlicka M, Zedkova I, Blatny M, Urbanek T.
    Neuro Endocrinol Lett; 2009 Dec; 30(2):256-61. PubMed ID: 19675512
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clozapine and weight gain.
    Theisen FM, Cichon S, Linden A, Martin M, Remschmidt H, Hebebrand J.
    Am J Psychiatry; 2001 May; 158(5):816. PubMed ID: 11329412
    [No Abstract] [Full Text] [Related]

  • 9. Successful treatment with clozapine at higher doses after clozapine-induced priapism.
    de Nesnera A.
    J Clin Psychiatry; 2003 Nov; 64(11):1394-5. PubMed ID: 14658959
    [No Abstract] [Full Text] [Related]

  • 10. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
    Müller DJ, Klempan TA, De Luca V, Sicard T, Volavka J, Czobor P, Sheitman BB, Lindenmayer JP, Citrome L, McEvoy JP, Lieberman JA, Honer WG, Kennedy JL.
    Neurosci Lett; 2005 May 06; 379(2):81-9. PubMed ID: 15823421
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Zonisamide-induced weight loss in schizophrenia: case series.
    Yang J, Lee MS, Joe SH, Jung IK, Kim SH.
    Clin Neuropharmacol; 2010 May 06; 33(2):104-6. PubMed ID: 19935403
    [Abstract] [Full Text] [Related]

  • 13. Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment.
    Wang YC, Bai YM, Chen JY, Lin CC, Lai IC, Liou YJ.
    Hum Psychopharmacol; 2010 May 06; 25(4):303-9. PubMed ID: 20521320
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
    De Luca V, Müller DJ, Hwang R, Lieberman JA, Volavka J, Meltzer HY, Kennedy JL.
    Hum Psychopharmacol; 2007 Oct 06; 22(7):463-7. PubMed ID: 17702092
    [Abstract] [Full Text] [Related]

  • 17. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM, Rittmannsberger H.
    Psychiatr Prax; 2006 May 06; 33(4):194-6. PubMed ID: 16680627
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
    Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Xu Q, Shen Y, Haile CN, Kosten TA, Kosten TR.
    J Psychiatr Res; 2007 Dec 06; 41(12):997-1004. PubMed ID: 17095017
    [Abstract] [Full Text] [Related]

  • 20. Importance of oral glucose tolerance test in patient with schizophrenia.
    Margetić B, Aukst-Margetić B, Badanjak A.
    Psychiatr Danub; 2005 Jun 06; 17(1-2):94-6. PubMed ID: 16395850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.